THE ROLES OF CD8+ AND CD4+ CELLS IN TUMOR REJECTION

被引：24

作者：

UDONO, H

MIENO, M

SHIKU, H

NAKAYAMA, E

机构：

来源：

JAPANESE JOURNAL OF CANCER RESEARCH | 1989年 / 80卷 / 07期

关键词：

D O I：

10.1111/j.1349-7006.1989.tb01692.x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：649 / 654

页数：6

共 23 条

[1]

BATEMAN WJ, 1987, IMMUNOLOGY, V61, P317

[2]

DAILEY MO, 1984, P NATL ACAD SCI USA, V79, P5384

[3]

DIALYNAS DP, 1983, J IMMUNOL, V131, P2445

[4]

EBERLEIN TJ, 1982, J EXP MED, V156, P385

[5]

ENGERS HD, 1984, J IMMUNOL, V133, P1664

[6]

FUJIWARA H, 1984, J IMMUNOL, V133, P1671

[7] ERADICATION OF DISSEMINATED MURINE LEUKEMIA BY CHEMO-IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE AND ADOPTIVELY TRANSFERRED IMMUNE SYNGENEIC LYMPHOCYTES-LYT-1+2- [J].

GREENBERG, PD ;

CHEEVER, MA ;

FEFER, A .

JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (03) :952-963

[8] EFFECTOR-CELLS IN ALLELIC H-2 CLASS I-INCOMPATIBLE SKIN-GRAFT REJECTION [J].

ICHIKAWA, T ;

NAKAYAMA, E ;

UENAKA, A ;

MONDEN, M ;

MORI, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (04) :982-990

[9]

KANEKO Y, 1980, J IMMUNOL, V125, P2031

[10] FBL-REACTIVE CD8+ CYTO-TOXIC AND CD4+ HELPER LYMPHOCYTES-T RECOGNIZE DISTINCT FRIEND MURINE LEUKEMIA VIRUS-ENCODED ANTIGENS [J].

KLARNET, JP ;

KERN, DE ;

OKUNO, K ;

HOLT, C ;

LILLY, F ;

GREENBERG, PD .

JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (02) :457-467

← 1 2 3 →